BioNTech CEO says current vaccine likely to protect against severe COVID from Omicron

Lab tests are underway over the next two weeks to analyse the blood of people who had two or three doses of BioNTech's Comirnaty vaccine to see if antibodies found in that blood inactivate Omicron, shedding light on whether new vaccines are needed.

from International-News-Economic Times https://ift.tt/3d9F99i
via IFTTT

SHARE